TLR4 rs4986791: Understanding the p.Thr399Ile Variant

What each genotype means

What is rs4986791?

The variant rs4986791 is a specific genetic change located within the TLR4 gene. In scientific literature, this is often referred to as a missense mutation, meaning the change in the DNA sequence leads to a substitution of one amino acid for another in the resulting protein—specifically, a threonine to isoleucine change at position 399 (p.Thr399Ile). This variant is frequently discussed alongside another nearby variant, rs4986790 (p.Asp299Gly), as they are known to co-segregate in certain populations, particularly among individuals of European ancestry. Because they are often inherited together, researchers sometimes find it challenging to isolate the specific functional impact of rs4986791 versus its neighbor. The variant is situated in the extracellular domain of the TLR4 protein, which is the part of the receptor that interacts with the external environment to detect potential threats.

The Role of the TLR4 Gene

The TLR4 gene encodes the Toll-like receptor 4 protein, a critical component of the innate immune system. This receptor acts as a sentinel, primarily responsible for recognizing lipopolysaccharide (LPS), a molecule found on the outer membrane of Gram-negative bacteria. When TLR4 detects these bacterial signals, it triggers a signaling cascade that activates the immune system to fight off potential infections. Because of its central role in detecting pathogens, TLR4 is essential for the body's initial defense against various microbes. Research has shown that the TLR4 protein is highly conserved across species, highlighting its evolutionary importance. Variations in this gene, such as rs4986791, are of interest to scientists because they may alter how effectively the immune system recognizes and responds to bacterial threats, potentially influencing an individual's susceptibility to inflammatory diseases or infections.

Research and Evidence Strength

The evidence linking rs4986791 to clinical outcomes is considered limited and sometimes conflicting. While some studies have suggested that this variant, often in combination with rs4986790, may influence susceptibility to sepsis or the body's response to Gram-negative pathogens, other research has failed to replicate these findings or has attributed the functional effects primarily to the neighboring rs4986790 variant rather than rs4986791 itself. For instance, some laboratory studies using cell models have indicated that while the p.Asp299Gly variant impairs TLR4 signaling, the p.Thr399Ile variant may not have the same functional impact on LPS responsiveness. Consequently, the clinical significance of rs4986791 remains a subject of ongoing investigation. It is important to note that genetic associations observed in research studies do not necessarily translate to individual health outcomes, and the complex nature of immune responses means that many factors beyond a single SNP contribute to disease risk.

Population Frequency

The frequency of the rs4986791 variant varies significantly across different global populations. In European populations, the minor allele frequency (MAF) is typically reported in the range of approximately 0.04 to 0.08. This means that a small but notable percentage of individuals in these groups carry at least one copy of the variant. In contrast, the variant is much less common or absent in many other ancestral groups. Because of this uneven distribution, most research regarding this SNP has been conducted in European cohorts, which limits our current understanding of how this variant might function or influence health in other populations. Genetic diversity is a key factor in how variants like rs4986791 are distributed, and researchers emphasize the need for more diverse studies to fully understand the global impact of this genetic change.

What This Information Means for You

If you have information about your status for the rs4986791 variant, it is important to view it within the context of current scientific uncertainty. This variant is not a diagnostic tool, and it cannot predict whether you will develop a specific disease or how you will respond to an infection. Genetic associations are statistical observations made across large groups of people and do not provide a definitive health forecast for any single individual. You should never use this information to make medical decisions or change any prescribed treatments. If you have concerns about your immune health, susceptibility to infections, or any other medical condition, the most appropriate step is to consult with a qualified healthcare professional. They can provide guidance based on your full medical history, clinical symptoms, and established diagnostic testing, rather than relying on individual genetic markers.

Frequently asked questions

Sources & further reading

Related variants in TLR4